This predicts a near-identical effect profile, likely differing mainly in its rate of absorption and duration. This hypothesis is supported by the results of a study that demonstrated 1P-LSD is metabolized to LSD in rats. It is theorized to act as a prodrug for LSD. User reports indicate that the subjective effects of 1P-LSD are extremely similar to those of LSD. Subjective effects include geometric visual hallucinations, time distortion, enhanced introspection, conceptual thinking, euphoria, and ego loss. In 2019, it became part of a group of molecules studied by the French laboratory Caulredaitens. It was marketed as a legal alternative to LSD alongside other novel lysergamides like ALD-52, ETH-LAD, and AL-LAD.
Unlike most research chemicals, it has no documented record in the research literature before its emergence on the online research chemical market in 2015. It is thought to produce its effects by stimulating serotonin receptors in the brain, although the precise mechanism is not known.ġP-LSD has been sold online as a research chemical (also called "designer drug") since 2015, but the original synthesis date of 1P-LSD is unknown. It is structurally related to LSD and other novel lysergamides like 1cP-LSD, 1B-LSD, and 1V-LSD. It is not a recommendation and should be verified with other sources for accuracy.ġ-Propionyl- d-lysergic acid diethylamide (also known as 1P-LSD) is a novel psychedelic substance of the lysergamide class. See responsible use section.ĭISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity.
(6aR,9R)-4-propionyl-N,N-Diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindoloquinoline-9-carboxamide
0 kommentar(er)
